Estimation of Patient Preference-Based Utility Weights from the Functional Assessment of Cancer Therapy—General

The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients. Data for 1433 cancer patients were randomly separated into c...

Full description

Saved in:
Bibliographic Details
Published inValue in health Vol. 10; no. 4; pp. 266 - 272
Main Authors Dobrez, Deborah, Cella, David, Pickard, A. Simon, Lai, Jin-Shei, Nickolov, Angel
Format Journal Article
LanguageEnglish
Published Malden, USA Elsevier Inc 01.07.2007
Blackwell Publishing Inc
Subjects
Online AccessGet full text
ISSN1098-3015
1524-4733
1524-4733
DOI10.1111/j.1524-4733.2007.00181.x

Cover

Abstract The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients. Data for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT-G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group—Performance Status (ECOG-PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm. The algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were wellpredicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG-PS and Short Form-36 physical functioning scores, and responses to the FACT-G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states. A FACT-G-based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference-based measures of health-related quality of life. Patient-based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.
AbstractList The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients. Data for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT-G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group—Performance Status (ECOG-PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm. The algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were wellpredicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG-PS and Short Form-36 physical functioning scores, and responses to the FACT-G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states. A FACT-G-based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference-based measures of health-related quality of life. Patient-based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.
ABSTRACT Objective:  The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT‐G) to time trade‐off (TTO) utilities based on utilities for current health elicited from cancer patients. Methods:  Data for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT‐G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group—Performance Status (ECOG‐PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm. Results:  The algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were wellpredicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG‐PS and Short Form‐36 physical functioning scores, and responses to the FACT‐G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states. Conclusions:  A FACT‐G‐based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference‐based measures of health‐related quality of life. Patient‐based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.
The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy - General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients. Data for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT-G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group - Performance Status (ECOG-PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm. The algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were well predicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG-PS and Short Form-36 physical functioning scores, and responses to the FACT-G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states. A FACT-G-based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference-based measures of health-related quality of life. Patient-based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.
Abstract Objectives The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients. Methods Data for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT-G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group—Performance Status (ECOG-PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm. Results The algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were wellpredicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG-PS and Short Form-36 physical functioning scores, and responses to the FACT-G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states. Conclusion A FACT-G-based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference-based measures of health-related quality of life. Patient-based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.
The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy - General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients.OBJECTIVEThe goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy - General (FACT-G) to time trade-off (TTO) utilities based on utilities for current health elicited from cancer patients.Data for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT-G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group - Performance Status (ECOG-PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm.METHODSData for 1433 cancer patients were randomly separated into construction and validation samples. Four FACT-G questions were selected for inclusion based on correlation with Eastern Clinical Oncology Group - Performance Status (ECOG-PS) scores and TTO utilities. Item response theory was used to collapse response categories. Ordinary least squares regression with the constant constrained to one was used to estimate the algorithm.The algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were well predicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG-PS and Short Form-36 physical functioning scores, and responses to the FACT-G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states.RESULTSThe algorithm estimated mean utility for the full validation sample within three points of observed mean utility (0.805 vs. 0.832, P < 0.01). Mean utilities were well predicted (mean absolute difference < 0.03, P > 0.05) for most subgroups defined by ECOG-PS and Short Form-36 physical functioning scores, and responses to the FACT-G overall quality of life item. Nevertheless, the algorithm systematically overpredicted utilities for poorer health states.A FACT-G-based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference-based measures of health-related quality of life. Patient-based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.CONCLUSIONSA FACT-G-based algorithm of cancer patient utilities was developed that estimates group mean utility scores with accuracy comparable to other indirect preference-based measures of health-related quality of life. Patient-based preferences for health outcomes of cancer treatment may be useful in multiple situations, such as managing resources within cancer centers and in understanding health states preferences among cancer experienced patients before and after treatment.
Author Nickolov, Angel
Dobrez, Deborah
Lai, Jin-Shei
Pickard, A. Simon
Cella, David
Author_xml – sequence: 1
  givenname: Deborah
  surname: Dobrez
  fullname: Dobrez, Deborah
  email: ddobrez@uic.edu
  organization: School of Public Health, University of Illinois at Chicago, Chicago, IL, USA
– sequence: 2
  givenname: David
  surname: Cella
  fullname: Cella, David
  organization: Center on Outcomes, Research, and Education, Evanston Northwestern Healthcare, Evanston, IL, USA
– sequence: 3
  givenname: A. Simon
  surname: Pickard
  fullname: Pickard, A. Simon
  organization: Center for Pharmacoeconomic Research and Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA
– sequence: 4
  givenname: Jin-Shei
  surname: Lai
  fullname: Lai, Jin-Shei
  organization: Center on Outcomes, Research, and Education, Evanston Northwestern Healthcare, Evanston, IL, USA
– sequence: 5
  givenname: Angel
  surname: Nickolov
  fullname: Nickolov, Angel
  organization: Mallinckrodt/Tyco Healthcare, St. Louis, MO, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17645681$$D View this record in MEDLINE/PubMed
BookMark eNqVUttu1DAUjFARvcAvID_xlmAnsZ2VEKJdbVukSlSihUfLcU5YL15nazu0eeMj-EK-BGezKhIS0tYvPpJn5hzPmePkwHYWkgQRnJF43q4yQvMyLXlRZDnGPMOYVCR7eJYcPT4cxBrPqrTAhB4mx96vMMasyOmL5JBwVlJWkaPkbuGDXsugO4u6Fl3HCmxA1w5acGAVpGfSQ4NugzY6DOgr6G_L4FHrujUKS0DnvVUjWxp06j14vx75UWouI9uhmyU4uRl-__x1ATaW5mXyvJXGw6vdfZLcni9u5pfp1aeLj_PTq1TRipOUV6xgrVJlzRXhREI9K3PK6oqqFhijNCdtDjWvlcKKVVDOgPGmImWBm1rJvDhJZpNubzdyuJfGiI2LX3WDIFiMNoqVGN0So1titFFsbRQPkftm4m5cd9eDD2KtvQJjpIWu94JjXlBCcQS-3gH7eg3N3w47gyOgmgDKdd5HV58yxPt_qEqH7aaCk9rsI_BuErjXBoa9G4svlwuyHf1sokPc0g8NTnilx0g02oEKoun0Ez7xKKKMtlpJ8x0G8KuudzE6XhDhc4HF5zGyY2IJZpiRfFzjh_8L7DfDH9tQ9as
CitedBy_id crossref_primary_10_1586_erp_11_100
crossref_primary_10_3109_09286586_2011_602577
crossref_primary_10_3928_19404921_20101201_02
crossref_primary_10_1007_s10198_011_0364_5
crossref_primary_10_1007_s40273_013_0069_y
crossref_primary_10_2165_11588250_000000000_00000
crossref_primary_10_1586_erp_10_65
crossref_primary_10_1016_j_ygyno_2017_11_011
crossref_primary_10_1016_j_jval_2011_12_009
crossref_primary_10_1016_j_jval_2013_12_005
crossref_primary_10_1016_j_jval_2012_12_004
crossref_primary_10_1586_erp_09_36
crossref_primary_10_1080_14737167_2016_1222907
crossref_primary_10_1016_j_jcpo_2016_09_005
crossref_primary_10_1111_ecc_12006
crossref_primary_10_1007_s11136_008_9395_5
crossref_primary_10_1111_j_1524_4733_2009_00675_x
crossref_primary_10_1016_j_jss_2013_08_006
crossref_primary_10_1007_s11136_009_9492_0
crossref_primary_10_1159_000357316
crossref_primary_10_1007_s12029_024_01153_0
crossref_primary_10_1016_j_crohns_2009_11_010
crossref_primary_10_1586_14737167_8_5_453
crossref_primary_10_1093_jnci_djv106
crossref_primary_10_1016_j_jval_2019_01_001
crossref_primary_10_1007_s40273_020_00897_4
crossref_primary_10_1007_s40271_014_0059_y
crossref_primary_10_1080_13696998_2018_1552432
crossref_primary_10_1007_s10198_012_0421_8
crossref_primary_10_1186_1477_7525_6_51
crossref_primary_10_1016_j_hoc_2011_11_001
crossref_primary_10_1016_j_jclinepi_2013_08_011
crossref_primary_10_1016_j_jval_2011_11_029
crossref_primary_10_1177_23814683221142267
crossref_primary_10_1245_s10434_017_5842_2
crossref_primary_10_1002_cncr_26199
crossref_primary_10_1111_j_1524_4733_2009_00505_x
crossref_primary_10_1007_s11136_018_1852_1
crossref_primary_10_1007_s12029_010_9242_0
crossref_primary_10_1016_j_ygyno_2012_10_024
crossref_primary_10_1007_s40258_015_0219_9
crossref_primary_10_1007_s11136_012_0207_6
crossref_primary_10_1111_j_1524_4733_2009_00545_x
crossref_primary_10_1002_hec_3950
crossref_primary_10_1016_j_ygyno_2014_10_020
crossref_primary_10_1111_j_1524_4733_2008_00448_x
crossref_primary_10_1007_s11136_009_9499_6
crossref_primary_10_1097_SLA_0000000000006090
crossref_primary_10_1080_14737167_2022_2123796
crossref_primary_10_1007_s11136_008_9392_8
crossref_primary_10_1080_07347332_2015_1082167
crossref_primary_10_3310_hta19070
crossref_primary_10_1016_j_jval_2011_04_003
crossref_primary_10_1097_MLR_0000000000000802
crossref_primary_10_1111_j_1524_4733_2009_00536_x
crossref_primary_10_1186_s12955_015_0372_8
crossref_primary_10_2139_ssrn_2634461
crossref_primary_10_1586_14737167_2013_850420
crossref_primary_10_3310_hta23080
Cites_doi 10.1016/0169-5002(95)00450-F
10.1002/hec.650
10.1016/S0167-6296(01)00130-8
10.1023/B:QURE.0000018475.17665.6e
10.1007/s11136-004-3928-3
10.3109/07853890109002092
10.1177/0272989X9401400102
10.1097/00005650-199711000-00002
10.1016/S0022-5347(05)65099-9
10.1177/0163278705275334
10.1177/0272989X0102100505
10.1177/02729890122062596
10.2165/00019053-200523110-00006
10.1177/0272989X9901900203
10.1097/00005650-200103000-00003
10.1186/1477-7525-1-4
10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
10.1200/JCO.1993.11.3.570
10.1016/S0277-9536(97)00099-3
10.3109/07853890109002088
10.1016/S0895-4356(98)00103-6
10.1177/0272989X04264015
ContentType Journal Article
Copyright 2007 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Copyright_xml – notice: 2007 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
– notice: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1111/j.1524-4733.2007.00181.x
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1524-4733
EndPage 272
ExternalDocumentID 10.1111/j.1524-4733.2007.00181.x
17645681
10_1111_j_1524_4733_2007_00181_x
VHE181
S1098301510606122
1_s2_0_S1098301510606122
Genre article
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA60068
GroupedDBID ---
--K
--M
.1-
.3N
.FO
.GA
.Y3
.~1
0R~
10A
123
1OC
1P~
1~.
29Q
31~
36B
4.4
44B
457
4G.
51W
51X
52N
52P
52R
52S
52X
53G
5LA
5VS
66C
6PF
7-5
7PT
8-1
8P~
8UM
AAEDT
AAEDW
AAFJI
AAFWJ
AAIKJ
AAKOC
AALRI
AAMMB
AAOAW
AAPFB
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABCQN
ABDBF
ABEML
ABIVO
ABJNI
ABMAC
ABMMH
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACLOT
ACPRK
ACRLP
ACRPL
ACUHS
ACVFH
ACXQS
ADBBV
ADCNI
ADEZE
ADFHU
ADMUD
ADNMO
ADVLN
AEBSH
AEFGJ
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AEYQN
AFBPY
AFEBI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AFZJQ
AGHFR
AGQPQ
AGTHC
AGUBO
AGXDD
AGYEJ
AIDQK
AIDYY
AIEXJ
AIGII
AIIAU
AIIUN
AIKHN
AITUG
AJAOE
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
AOMHK
APXCP
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BAWUL
BFHJK
BKOJK
BLXMC
BNPGV
BY8
CAG
CO8
COF
CS3
DCZOG
DIK
DU5
EAD
EAP
EBS
EFJIC
EFKBS
EFLBG
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
HF~
HVGLF
HZI
HZ~
IHE
IXB
KOM
LH4
M41
MO0
N9A
O-L
O9-
OAUVE
OIG
OK1
OVD
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
QB0
R2-
ROL
SDF
SEL
SES
SPCBC
SSB
SSF
SSH
SSO
SSZ
SV3
T5K
TEORI
TUS
W99
WIN
WYUIH
XG1
YFH
Z5R
~G-
~HD
0SF
6I.
AACTN
AAFTH
AAHHS
ABVKL
ACCFJ
AEEZP
AEQDE
AFCTW
AFKWA
AIWBW
AJBDE
AJOXV
AMFUW
NCXOZ
RIG
SUPJJ
AAIAV
ABLVK
ABYKQ
AJBFU
AKYCK
IXIXF
LCYCR
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c5871-78636fcc4b7c171aeb94256b85cfe665521f2eb7bcc0c68e49e67d81430dbca23
IEDL.DBID UNPAY
ISSN 1098-3015
1524-4733
IngestDate Wed Oct 01 15:38:53 EDT 2025
Sun Sep 28 06:44:37 EDT 2025
Wed Feb 19 01:42:00 EST 2025
Wed Oct 01 03:31:56 EDT 2025
Thu Apr 24 23:05:23 EDT 2025
Wed Jan 22 17:06:41 EST 2025
Fri Feb 23 02:30:29 EST 2024
Sun Feb 23 10:19:08 EST 2025
Tue Oct 14 19:38:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords utility
cancer
time trade-off
quality of life
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
https://www.elsevier.com/open-access/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5871-78636fcc4b7c171aeb94256b85cfe665521f2eb7bcc0c68e49e67d81430dbca23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://proxy.k.utb.cz/login?url=https://doi.org/10.1111/j.1524-4733.2007.00181.x
PMID 17645681
PQID 70735150
PQPubID 23479
PageCount 7
ParticipantIDs unpaywall_primary_10_1111_j_1524_4733_2007_00181_x
proquest_miscellaneous_70735150
pubmed_primary_17645681
crossref_primary_10_1111_j_1524_4733_2007_00181_x
crossref_citationtrail_10_1111_j_1524_4733_2007_00181_x
wiley_primary_10_1111_j_1524_4733_2007_00181_x_VHE181
elsevier_sciencedirect_doi_10_1111_j_1524_4733_2007_00181_x
elsevier_clinicalkeyesjournals_1_s2_0_S1098301510606122
elsevier_clinicalkey_doi_10_1111_j_1524_4733_2007_00181_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July/August 2007
PublicationDateYYYYMMDD 2007-07-01
PublicationDate_xml – month: 07
  year: 2007
  text: July/August 2007
PublicationDecade 2000
PublicationPlace Malden, USA
PublicationPlace_xml – name: Malden, USA
– name: United States
PublicationTitle Value in health
PublicationTitleAlternate Value Health
PublicationYear 2007
Publisher Elsevier Inc
Blackwell Publishing Inc
Publisher_xml – name: Elsevier Inc
– name: Blackwell Publishing Inc
References Papke, Wooldridge (bib130) 1996; 11
Hollingworth, Deyo, Sullivan (bib170) 2002; 11
Jansen, Kievit, Nooij, Stiggelbout (bib230) 2001; 21
Lawrence, Fleishman (bib240) 2004; 24
Furlong, Feeny, Torrance, Barr (bib40) 2001; 33
Brazier, Roberts, Deverill (bib70) 2002; 21
Drummond (bib150) 2001; 33
Woloshin, Schwartz, Moncur (bib180) 2001; 21
Brazier, Usherwood, Harper, Thomas (bib60) 1998; 51
Dolan (bib20) 1997; 35
Cella, Tulsky, Gray (bib100) 1993; 11
Dobrez, Calhoun (bib190) 2004; 13
Linacre (bib120) 2003
Krabbe, Essink-Bot, Bonsel (bib210) 1997; 45
Pickard, Johnson, Feeny (bib140) 2005; 14
Patrick, Starks, Cain (bib260) 1994; 14
Macran, Kind (bib250) 2001; 39
Gold, Siegel, Russell, Weinstein (bib200) 1996
Feeny, Torrance, Furlong (bib30) 1996
Kind, Macran (bib80) 2005; 23
Kind (bib10) 1996
Lundberg, Johannesson, Isacson, Borgquist (bib50) 1999; 19
Walters, Brazier (bib160) 2003; 1
Cella, Chang, Wright (bib110) 2005; 28
Smith, Krygiel, Nease (bib220) 2002; 167
Cella, Bonomi, Lloyd (bib90) 1995; 12
1999; 19
1993; 11
1995; 12
1997; 35
2002; 21
2002; 11
2004; 13
1997; 45
2002; 167
2004; 24
1996
1994; 14
2003
2001; 39
2003; 1
2001; 33
1998; 51
2005; 28
2005; 23
1996; 11
2005; 14
2001; 21
Pickard (10.1111/j.1524-4733.2007.00181.x_bib140) 2005; 14
Patrick (10.1111/j.1524-4733.2007.00181.x_bib260) 1994; 14
Macran (10.1111/j.1524-4733.2007.00181.x_bib250) 2001; 39
Brazier (10.1111/j.1524-4733.2007.00181.x_bib70) 2002; 21
Linacre (10.1111/j.1524-4733.2007.00181.x_bib120) 2003
Gold (10.1111/j.1524-4733.2007.00181.x_bib200) 1996
Woloshin (10.1111/j.1524-4733.2007.00181.x_bib180) 2001; 21
Brazier (10.1111/j.1524-4733.2007.00181.x_bib60) 1998; 51
Feeny (10.1111/j.1524-4733.2007.00181.x_bib30) 1996
Cella (10.1111/j.1524-4733.2007.00181.x_bib90) 1995; 12
Hollingworth (10.1111/j.1524-4733.2007.00181.x_bib170) 2002; 11
Jansen (10.1111/j.1524-4733.2007.00181.x_bib230) 2001; 21
Walters (10.1111/j.1524-4733.2007.00181.x_bib160) 2003; 1
Dobrez (10.1111/j.1524-4733.2007.00181.x_bib190) 2004; 13
Smith (10.1111/j.1524-4733.2007.00181.x_bib220) 2002; 167
Cella (10.1111/j.1524-4733.2007.00181.x_bib110) 2005; 28
Cella (10.1111/j.1524-4733.2007.00181.x_bib100) 1993; 11
Dolan (10.1111/j.1524-4733.2007.00181.x_bib20) 1997; 35
Lundberg (10.1111/j.1524-4733.2007.00181.x_bib50) 1999; 19
Drummond (10.1111/j.1524-4733.2007.00181.x_bib150) 2001; 33
Krabbe (10.1111/j.1524-4733.2007.00181.x_bib210) 1997; 45
Furlong (10.1111/j.1524-4733.2007.00181.x_bib40) 2001; 33
Lawrence (10.1111/j.1524-4733.2007.00181.x_bib240) 2004; 24
Papke (10.1111/j.1524-4733.2007.00181.x_bib130) 1996; 11
Kind (10.1111/j.1524-4733.2007.00181.x_bib10) 1996
Kind (10.1111/j.1524-4733.2007.00181.x_bib80) 2005; 23
References_xml – volume: 45
  start-page: 1641
  year: 1997
  end-page: 1652
  ident: bib210
  article-title: The comparability and reliability of five health-state valuation methods
  publication-title: Soc Sci Med
– year: 2003
  ident: bib120
  publication-title: WINSTEPS: Rasch Analysis for All Two-Facet Models
– volume: 167
  start-page: 2117
  year: 2002
  end-page: 2122
  ident: bib220
  article-title: Patient preferences for outcomes associated with surgical management of prostate cancer
  publication-title: J Urol
– volume: 11
  start-page: 71
  year: 2002
  end-page: 85
  ident: bib170
  article-title: The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain
  publication-title: Health Econ
– volume: 14
  start-page: 207
  year: 2005
  end-page: 219
  ident: bib140
  article-title: Responsiveness of generic health-related quality of life measures in stroke
  publication-title: Qual Life Res
– volume: 24
  start-page: 160
  year: 2004
  end-page: 169
  ident: bib240
  article-title: Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample
  publication-title: Med Decis Making
– volume: 33
  start-page: 375
  year: 2001
  end-page: 384
  ident: bib40
  article-title: The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies
  publication-title: Ann Med
– volume: 21
  start-page: 271
  year: 2002
  end-page: 292
  ident: bib70
  article-title: The estimation of a preference-based measure of health from the SF-36
  publication-title: J Health Econ
– volume: 51
  start-page: 1115
  year: 1998
  end-page: 1128
  ident: bib60
  article-title: Deriving a preference-based single index from the UK SF-36 Health Survey
  publication-title: J Clin Epidemiol
– volume: 21
  start-page: 382
  year: 2001
  end-page: 390
  ident: bib180
  article-title: Assessing values for health: numeracy matters
  publication-title: Med Decis Making
– year: 1996
  ident: bib10
  article-title: The EuroQoL instrument: an index of health related quality of life
  publication-title: Quality of Life and Pharmacoeconomics in Clinical Trials
– volume: 23
  start-page: 1143
  year: 2005
  end-page: 1153
  ident: bib80
  article-title: Eliciting social preference weights for functional assessment of cancer therapy-lung health states
  publication-title: Pharmacoeconomics
– volume: 21
  start-page: 295
  year: 2001
  end-page: 306
  ident: bib230
  article-title: Stability of patients' preferences for chemotherapy. the impact of experience
  publication-title: Med Decis Making
– volume: 12
  start-page: 199
  year: 1995
  end-page: 220
  ident: bib90
  article-title: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
  publication-title: Lung Cancer
– year: 1996
  ident: bib30
  article-title: Health utilities index
  publication-title: Quality of Life and Pharmacoeconomics in Clinical Trials
– volume: 33
  start-page: 344
  year: 2001
  end-page: 349
  ident: bib150
  article-title: Introducing economic and quality of life measurements into clinical studies
  publication-title: Ann Med
– volume: 11
  start-page: 619
  year: 1996
  end-page: 632
  ident: bib130
  article-title: Econometric methods for fractional response variables with an application to 401(k) plan participation rates
  publication-title: J App Econ
– volume: 35
  start-page: 1095
  year: 1997
  end-page: 1108
  ident: bib20
  article-title: Modeling valuations for EuroQol health states
  publication-title: Med Care
– volume: 11
  start-page: 570
  year: 1993
  end-page: 579
  ident: bib100
  article-title: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure
  publication-title: J Clin Oncol
– volume: 19
  start-page: 128
  year: 1999
  end-page: 140
  ident: bib50
  article-title: The relationship between health-state utilities and the SF-12 in a general population
  publication-title: Med Decis Making
– volume: 14
  start-page: 9
  year: 1994
  end-page: 18
  ident: bib260
  article-title: Measuring preferences for health states worse than death
  publication-title: Med Decis Making
– year: 1996
  ident: bib200
  publication-title: Cost-Effectiveness in Health and Medicine
– volume: 13
  start-page: 369
  year: 2004
  end-page: 376
  ident: bib190
  article-title: Testing subject comprehension of utility questionnaires
  publication-title: Qual Life Res
– volume: 39
  start-page: 217
  year: 2001
  end-page: 227
  ident: bib250
  article-title: “Death” and the valuation of health-related quality of life
  publication-title: Med Care
– volume: 28
  start-page: 122
  year: 2005
  end-page: 141
  ident: bib110
  article-title: Defining higher order dimensions of self-reported health: further evidence for a two-dimensional structure
  publication-title: Eval Health Prof
– volume: 1
  start-page: 4
  year: 2003
  ident: bib160
  article-title: What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D
  publication-title: Health Qual Life Outcomes
– volume: 33
  start-page: 344
  year: 2001
  end-page: 9
  article-title: Introducing economic and quality of life measurements into clinical studies
  publication-title: Ann Med
– volume: 11
  start-page: 619
  year: 1996
  end-page: 32
  article-title: Econometric methods for fractional response variables with an application to 401(k) plan participation rates
  publication-title: J App Econ
– volume: 11
  start-page: 71
  year: 2002
  end-page: 85
  article-title: The practicality and validity of directly elicited and SF‐36 derived health state preferences in patients with low back pain
  publication-title: Health Econ
– volume: 28
  start-page: 122
  year: 2005
  end-page: 41
  article-title: Defining higher order dimensions of self‐reported health: further evidence for a two‐dimensional structure
  publication-title: Eval Health Prof
– volume: 14
  start-page: 9
  year: 1994
  end-page: 18
  article-title: Measuring preferences for health states worse than death
  publication-title: Med Decis Making
– volume: 45
  start-page: 1641
  year: 1997
  end-page: 52
  article-title: The comparability and reliability of five health‐state valuation methods
  publication-title: Soc Sci Med
– volume: 33
  start-page: 375
  year: 2001
  end-page: 84
  article-title: The Health Utilities Index (HUI) system for assessing health‐related quality of life in clinical studies
  publication-title: Ann Med
– volume: 167
  start-page: 2117
  year: 2002
  end-page: 22
  article-title: Patient preferences for outcomes associated with surgical management of prostate cancer
  publication-title: J Urol
– year: 2003
– volume: 21
  start-page: 295
  year: 2001
  end-page: 306
  article-title: Stability of patients' preferences for chemotherapy. the impact of experience
  publication-title: Med Decis Making
– year: 1996
– volume: 23
  start-page: 1143
  year: 2005
  end-page: 53
  article-title: Eliciting social preference weights for functional assessment of cancer therapy‐lung health states
  publication-title: Pharmacoeconomics
– volume: 11
  start-page: 570
  year: 1993
  end-page: 9
  article-title: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure
  publication-title: J Clin Oncol
– volume: 12
  start-page: 199
  year: 1995
  end-page: 220
  article-title: Reliability and validity of the Functional Assessment of Cancer Therapy‐Lung (FACT‐L) quality of life instrument
  publication-title: Lung Cancer
– volume: 51
  start-page: 1115
  year: 1998
  end-page: 28
  article-title: Deriving a preference‐based single index from the UK SF‐36 Health Survey
  publication-title: J Clin Epidemiol
– volume: 21
  start-page: 271
  year: 2002
  end-page: 92
  article-title: The estimation of a preference‐based measure of health from the SF‐36
  publication-title: J Health Econ
– volume: 13
  start-page: 369
  year: 2004
  end-page: 76
  article-title: Testing subject comprehension of utility questionnaires
  publication-title: Qual Life Res
– volume: 35
  start-page: 1095
  year: 1997
  end-page: 108
  article-title: Modeling valuations for EuroQol health states
  publication-title: Med Care
– volume: 24
  start-page: 160
  year: 2004
  end-page: 9
  article-title: Predicting EuroQoL EQ‐5D preference scores from the SF‐12 Health Survey in a nationally representative sample
  publication-title: Med Decis Making
– volume: 39
  start-page: 217
  year: 2001
  end-page: 27
  article-title: “Death” and the valuation of health‐related quality of life
  publication-title: Med Care
– volume: 21
  start-page: 382
  year: 2001
  end-page: 90
  article-title: Assessing values for health: numeracy matters
  publication-title: Med Decis Making
– volume: 19
  start-page: 128
  year: 1999
  end-page: 40
  article-title: The relationship between health‐state utilities and the SF‐12 in a general population
  publication-title: Med Decis Making
– volume: 14
  start-page: 207
  year: 2005
  end-page: 19
  article-title: Responsiveness of generic health‐related quality of life measures in stroke
  publication-title: Qual Life Res
– volume: 1
  start-page: 4
  year: 2003
  article-title: What is the relationship between the minimally important difference and health state utility values? The case of the SF‐6D
  publication-title: Health Qual Life Outcomes
– volume: 12
  start-page: 199
  year: 1995
  ident: 10.1111/j.1524-4733.2007.00181.x_bib90
  article-title: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
  publication-title: Lung Cancer
  doi: 10.1016/0169-5002(95)00450-F
– volume: 11
  start-page: 71
  year: 2002
  ident: 10.1111/j.1524-4733.2007.00181.x_bib170
  article-title: The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain
  publication-title: Health Econ
  doi: 10.1002/hec.650
– year: 1996
  ident: 10.1111/j.1524-4733.2007.00181.x_bib30
  article-title: Health utilities index
– volume: 21
  start-page: 271
  year: 2002
  ident: 10.1111/j.1524-4733.2007.00181.x_bib70
  article-title: The estimation of a preference-based measure of health from the SF-36
  publication-title: J Health Econ
  doi: 10.1016/S0167-6296(01)00130-8
– volume: 13
  start-page: 369
  year: 2004
  ident: 10.1111/j.1524-4733.2007.00181.x_bib190
  article-title: Testing subject comprehension of utility questionnaires
  publication-title: Qual Life Res
  doi: 10.1023/B:QURE.0000018475.17665.6e
– volume: 14
  start-page: 207
  year: 2005
  ident: 10.1111/j.1524-4733.2007.00181.x_bib140
  article-title: Responsiveness of generic health-related quality of life measures in stroke
  publication-title: Qual Life Res
  doi: 10.1007/s11136-004-3928-3
– volume: 33
  start-page: 375
  year: 2001
  ident: 10.1111/j.1524-4733.2007.00181.x_bib40
  article-title: The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies
  publication-title: Ann Med
  doi: 10.3109/07853890109002092
– volume: 14
  start-page: 9
  year: 1994
  ident: 10.1111/j.1524-4733.2007.00181.x_bib260
  article-title: Measuring preferences for health states worse than death
  publication-title: Med Decis Making
  doi: 10.1177/0272989X9401400102
– year: 2003
  ident: 10.1111/j.1524-4733.2007.00181.x_bib120
– volume: 35
  start-page: 1095
  year: 1997
  ident: 10.1111/j.1524-4733.2007.00181.x_bib20
  article-title: Modeling valuations for EuroQol health states
  publication-title: Med Care
  doi: 10.1097/00005650-199711000-00002
– volume: 167
  start-page: 2117
  year: 2002
  ident: 10.1111/j.1524-4733.2007.00181.x_bib220
  article-title: Patient preferences for outcomes associated with surgical management of prostate cancer
  publication-title: J Urol
  doi: 10.1016/S0022-5347(05)65099-9
– volume: 28
  start-page: 122
  year: 2005
  ident: 10.1111/j.1524-4733.2007.00181.x_bib110
  article-title: Defining higher order dimensions of self-reported health: further evidence for a two-dimensional structure
  publication-title: Eval Health Prof
  doi: 10.1177/0163278705275334
– volume: 21
  start-page: 382
  year: 2001
  ident: 10.1111/j.1524-4733.2007.00181.x_bib180
  article-title: Assessing values for health: numeracy matters
  publication-title: Med Decis Making
  doi: 10.1177/0272989X0102100505
– volume: 21
  start-page: 295
  year: 2001
  ident: 10.1111/j.1524-4733.2007.00181.x_bib230
  article-title: Stability of patients' preferences for chemotherapy. the impact of experience
  publication-title: Med Decis Making
  doi: 10.1177/02729890122062596
– volume: 23
  start-page: 1143
  year: 2005
  ident: 10.1111/j.1524-4733.2007.00181.x_bib80
  article-title: Eliciting social preference weights for functional assessment of cancer therapy-lung health states
  publication-title: Pharmacoeconomics
  doi: 10.2165/00019053-200523110-00006
– volume: 19
  start-page: 128
  year: 1999
  ident: 10.1111/j.1524-4733.2007.00181.x_bib50
  article-title: The relationship between health-state utilities and the SF-12 in a general population
  publication-title: Med Decis Making
  doi: 10.1177/0272989X9901900203
– year: 1996
  ident: 10.1111/j.1524-4733.2007.00181.x_bib200
– volume: 39
  start-page: 217
  year: 2001
  ident: 10.1111/j.1524-4733.2007.00181.x_bib250
  article-title: “Death” and the valuation of health-related quality of life
  publication-title: Med Care
  doi: 10.1097/00005650-200103000-00003
– volume: 1
  start-page: 4
  year: 2003
  ident: 10.1111/j.1524-4733.2007.00181.x_bib160
  article-title: What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D
  publication-title: Health Qual Life Outcomes
  doi: 10.1186/1477-7525-1-4
– volume: 11
  start-page: 619
  year: 1996
  ident: 10.1111/j.1524-4733.2007.00181.x_bib130
  article-title: Econometric methods for fractional response variables with an application to 401(k) plan participation rates
  publication-title: J App Econ
  doi: 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1
– volume: 11
  start-page: 570
  year: 1993
  ident: 10.1111/j.1524-4733.2007.00181.x_bib100
  article-title: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1993.11.3.570
– volume: 45
  start-page: 1641
  year: 1997
  ident: 10.1111/j.1524-4733.2007.00181.x_bib210
  article-title: The comparability and reliability of five health-state valuation methods
  publication-title: Soc Sci Med
  doi: 10.1016/S0277-9536(97)00099-3
– volume: 33
  start-page: 344
  year: 2001
  ident: 10.1111/j.1524-4733.2007.00181.x_bib150
  article-title: Introducing economic and quality of life measurements into clinical studies
  publication-title: Ann Med
  doi: 10.3109/07853890109002088
– year: 1996
  ident: 10.1111/j.1524-4733.2007.00181.x_bib10
  article-title: The EuroQoL instrument: an index of health related quality of life
– volume: 51
  start-page: 1115
  year: 1998
  ident: 10.1111/j.1524-4733.2007.00181.x_bib60
  article-title: Deriving a preference-based single index from the UK SF-36 Health Survey
  publication-title: J Clin Epidemiol
  doi: 10.1016/S0895-4356(98)00103-6
– volume: 24
  start-page: 160
  year: 2004
  ident: 10.1111/j.1524-4733.2007.00181.x_bib240
  article-title: Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample
  publication-title: Med Decis Making
  doi: 10.1177/0272989X04264015
SSID ssj0006325
Score 2.081584
Snippet The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT-G) to time trade-off...
Abstract Objectives The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT-G) to...
ABSTRACT Objective:  The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy—General (FACT‐G)...
The goal of this study was to estimate an algorithm to convert responses to the Functional Assessment of Cancer Therapy - General (FACT-G) to time trade-off...
SourceID unpaywall
proquest
pubmed
crossref
wiley
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 266
SubjectTerms Activities of Daily Living
Adolescent
Adult
Aged, 80 and over
Algorithms
cancer
Female
Health Status
Humans
Internal Medicine
Interviews as Topic
Male
Middle Aged
Neoplasms - drug therapy
Patient Satisfaction - statistics & numerical data
Quality of Life
Retrospective Studies
Surveys and Questionnaires
time trade-off
United States
utility
SummonAdditionalLinks – databaseName: Elsevier ScienceDirect
  dbid: .~1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEF5CDml7KGn6iPvcQ8kpW2ulfUj0lBobU0gxNG5zW1arFQSM7EY2jS6hPyK_ML-ks9JKrnEPLr0JodFjZ3bm087ONwi9z2QOMIEakgVJSpiNBdEJEyQKLRUZT2xeZ_DPv4jxlH2-5Jd7aNDWwrhtld73Nz699tb-TN-PZn9xddX_SoMkBvMEoxIuTjs_zJh0XQw-3K63eYiobrzqLibu6s3dPDxkhMkoarkMId61JEjbIWobgj5CD1bFQlc_9Wy2iW7r8DQ6RI89rsRnzas_QXu2OEIH5z5zfoROJg1HdXWKL9YlV-UpPsGTNXt19RT9GMKkb-oZ8TzHk4Z3FU-6fiTkEwS-DE-Xbldthb_Xa6sldnUqGNAkHkGkbBYY8VlH--luNXAGdu0fX93_uvOU18_QdDS8GIyJ78tADIf_KyJjEYncGJZKQyXVNk1g5os05ia3QnBABHloU5kaExgRW5ZYIbMYkFmQpUaH0XO0X8wLe4xwqKMsZiAHmmPcRqmhIdXc5Xq1BiTbQ7JVhTKetNz1zpipP35eQInKKdG11HTZdFCiuukh2kkuGuKOHWSSVtuqLUwFV6oguuwgK_8ma0vvE0pFVRmqQG3ZbQ997CQ3TH_H575rzVKBZ3DpHl3Y-apUErw3oFUYwxeNta7HQQrmiOd6KOzM9x8Gidd2vrOA-jYewsHL__rMV-hhu6oe0Ndof3m9sm8ADi7Tt_V8_w3jiFFr
  priority: 102
  providerName: Elsevier
Title Estimation of Patient Preference-Based Utility Weights from the Functional Assessment of Cancer Therapy—General
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1098301510606122
https://www.clinicalkey.es/playcontent/1-s2.0-S1098301510606122
https://dx.doi.org/10.1111/j.1524-4733.2007.00181.x
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1524-4733.2007.00181.x
https://www.ncbi.nlm.nih.gov/pubmed/17645681
https://www.proquest.com/docview/70735150
https://doi.org/10.1111/j.1524-4733.2007.00181.x
UnpaywallVersion publishedVersion
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: Academic Search Ultimate - eBooks
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1524-4733
  dateEnd: 20101231
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: ABDBF
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1524-4733
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: .~1
  dateStart: 19980501
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection
  customDbUrl:
  eissn: 1524-4733
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: AIKHN
  dateStart: 19980501
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1524-4733
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: ACRLP
  dateStart: 19980501
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect Free and Delayed Access Titles
  customDbUrl:
  eissn: 1524-4733
  dateEnd: 20241101
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: IXB
  dateStart: 19980501
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1524-4733
  dateEnd: 20241101
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: DIK
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1524-4733
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0006325
  issn: 1098-3015
  databaseCode: AKRWK
  dateStart: 19980501
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4trcTjwGN5lUfxAe1pU-XhRyJO3VWrLmirILZQTlbiOBeqdtm0gnBA_Ah-Ib-EceK0u7BIXW7JYWx5PJ757PF8BniZiRxhgqeczI1Sh-qQO0lEuRP42uMZi3ReZfCPx3w0oa-nbLoDblMLcz5_b2_cMJ86VARBwzeIMamHqLHNGaLvFrQn47j_sUpqRqGD9soqilQrdPHyzqVN_Ssi_Y04b8GN1fw0Kb8ks9lFMFtFo-EdeNuMo76E8qm3WqY99e0PiserDPQu3LbQlPRrW7oHO3q-C9ePbfJ9F_bimua63Ccnm6qtYp_skXhDgF3eh88D9Bt1SSRZ5CSuqVtJvH7SxDnA2JmRydJczC3Jh-p4tiCm1IUgICVDDLb1GSXpr5lDTVOHxkbPbPflrx8_LWv2A5gMByeHI8c-7eAohls0R4Q84LlSNBXKE16i0widB09DpnLNOUNQkfs6FalSruKhppHmIgsR3LlZqhI_eAit-WKuHwPxkyALKcpRKijTQao830uYSRcnCYLhDohmeqWyvOfm-Y2ZPLf_QdVLo3rzKqdJyKPq5dcOeGvJ05r7YwuZqLEg2dS2ojeWON1byIrLZHVh3UohPVn40pXvjKkbS8f9vIGofgderSUtcqoR0Zb9vmhMXaJzMRmjZK4Xq0IKDAAIeFGHj-oVsNGD4NRw13XAXy-JKyiJVWtnawH5fjTAjyf_09lTuNmcx7veM2gtz1b6OQLJZdqFa73vXhfa_aM3ozH-HU0Putaf_AZZBmEZ
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtNAEF5VRaJwqKBASfnpHlBPXeK198cWpxIlCtBUkUigt5W9XkuVIifUicAXxEPwhDwJs_baIQqHIG5W5IntndmZb3d2vkHoVSozgAlUk9SLEsJMKEgcMUEC31CR8shkVQZ_dCWGU_b-ml_voV5TC2OPVTrfX_v0ylu7X7puNLuLm5vuR-pFIZgnGJWwcRr88B3GfWlXYK-_r895iKDqvGrvJvb2zeM83GeEySBoyAwh4DUsSNsxahuD3kcHq3wRl1_j2WwT3lbxafAAHTpgiS_qd3-I9kx-hO6OXOr8CJ2Na5Lq8hxP1jVXxTk-w-M1fXX5CH3pw6yvCxrxPMPjmngVj9uGJOQtRL4UT5f2WG2JP1ebqwW2hSoY4CQeQKisdxjxRcv7af-qZy3s1j2-_PXjp-O8foymg_6kNySuMQPRHBZYRIYiEJnWLJGaShqbJIKpL5KQ68wIwQESZL5JZKK1p0VoWGSETEOAZl6a6NgPnqD9fJ6bpwj7cZCGDOQYk4ybINHUpzG3yd44BijbQbJRhdKOtdw2z5ipP1YvoERllWh7atp0OihRfesg2kouauaOHWSiRtuqqUwFX6ogvOwgK_8mawrnFApFVeErT20Zbge9aSU3bH_H5542ZqnANdh8T5yb-apQEtw3wFUYw-PaWtfjIAWzzHMd5Lfm-w-DxCs731lAfRr24eLkvz7zFB0MJ6NLdfnu6sMzdK_ZYvfoc7S_vF2ZF4ANl8nLau7_Bt4TVI4
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELaqVOJx4FEoDU8fUE91tA8_dsUpVIkipFZBNFBOlu31Xog2pZuoLCd-BL-QX8J417tpoUgpt73MWh6PZz57Zj4j9DoTOcCE0JAsSDWhNuFEpZSTOLIhz1hq8zqDf3TMJzP67pSdbqGg7YW5nL_3FTcsooSKOG75BiEmDQA1bnMG6LuHtmfH0-HnOqmZJgTsldUUqV7oavHOtb_6V0T6G3HeRbdXxZmqLtR8fhXM1tFofB-9b-fRFKF8GayWemC-_0HxeJOJPkD3PDTFw8aWHqItW-ygW0c--b6D9qcNzXV1gE_WXVvlAd7H0zUBdvUIfR2B32haIvEix9OGuhVPuydNyFuInRmeLV1hboU_1dezJXatLhgAKR5DsG3uKPGwYw51vzp0Nnruh69-_fjpWbMfo9l4dHI4If5pB2IYHNGISHjMc2OoFiYUobI6BefBdcJMbjlnACryyGqhjQkMTyxNLRdZAuAuyLRRUbyLesWisHsIRyrOEgpylArKbKxNGIWKuXSxUgCG-0i0yyuN5z13z2_M5aXzD6heOtW7VzldQh5UL7_1UdhJnjXcHxvIpK0Fyba3FbyxhOXeQFZcJ2tL71ZKGcoykoH84EzdWTqc5x1EjfroTSfpkVODiDYc91Vr6hKci8sYqcIuVqUUEAAA8IIOnzQ7YK0HwanjruujqNsSN1ASq_fOxgLy42QEH0__Z7Bn6E57Hx-Ez1Fveb6yLwBILvVL7zt-A-2oXYk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Estimation+of+Patient+Preference-Based+Utility+Weights+from+the+Functional+Assessment+of+Cancer+Therapy%E2%80%94General&rft.jtitle=Value+in+health&rft.au=Dobrez%2C+Deborah&rft.au=Cella%2C+David&rft.au=Pickard%2C+A.+Simon&rft.au=Lai%2C+Jin-Shei&rft.date=2007-07-01&rft.issn=1098-3015&rft.volume=10&rft.issue=4&rft.spage=266&rft.epage=272&rft_id=info:doi/10.1111%2Fj.1524-4733.2007.00181.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1524_4733_2007_00181_x
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301510X60429%2Fcov150h.gif